Webb16 juli 2024 · Dutch biopharmaceutical company AM-Pharma has raised €116m from a European syndicate of new and existing investors. The funding will be used to support the initiation of a Phase III trial of its recombinant human alkaline phosphatase (recAP) therapeutic for patients with sepsis-associated acute kidney injury (SA-AKI). Allie Nawrat WebbAM‐Pharma is a clinical stage biopharmaceutical company, leading in the development of a treatment for acute kidney injury (AKI) with its innovative recombinant human Alkaline Phosphatase therapeutic (recAP) Stage: F Total Funds Raised: $247.7M Last Round Amount: $27.4M Funding Products Partners People News Network
Acute Kidney Injury Pipeline Analysis: Emerging therapies th...
Webb12 mars 2024 · recAP is AM‐Pharma’s proprietary recombinant human alkaline phosphatase (AP) built from two naturally occurring human isoforms of the AP enzyme, which is highly stable and active. 1. Would you consider attending a telehealth appointment in the metaverse? Yes, within the next 5 years Yes, in the future (>5 years) Maybe, feeling … Webb12 maj 2015 · Pfizer has acquired a minority equity interest in AM-Pharma, a privately held Dutch biopharmaceutical company focused on the development of recombinant human Alkaline Phosphatase (recAP ) for inflammatory diseases, and secured an exclusive option to acquire the remaining equity in the company. AM-Pharma CEO Erik van den Berg how do you pronounce rhiain
AM-Pharma Receives FDA and EMA Orphan Drug Designation to …
WebbAM-Pharma 1,887 من المتابعين على LinkedIn. A clinical stage biopharmaceutical company leading in the development of a treatment for acute kidney injury AM-Pharma BV is a biopharmaceutical company developing recombinant Alkaline Phosphatase for clinical use. Webb9 mars 2024 · AM‐Pharma is a biopharmaceutical company focused on the development of recAP (recombinant Human Alkaline Phosphatase) for treatment of Acute Kidney Injury (AKI), Ulcerative Colitis (UC), and... Webb15 maj 2024 · Key players such as ANG-3777 (BB3; Angion Biomedica), QPI1002 (Quark Pharmaceutical), ASP1128 (Astellas Pharma), MB-102 (MediBeacon), Ruconest (Conestat alfa; PharmingTechnologies), recAP (AM ... phone number for barnsley council